InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Pharma repurposing: Old drugs, new tricks

James Nurton, London


The development of new uses for existing drugs raises complex questions about patent law, regulation, economics and health policy. James Nurton reports from a recent conference hosted by UCL and Georgetown Law School

The story of thalidomide has three chapters. The first chapter ended in tragedy. The drug was developed by German company Grünenthal in the 1950s to treat morning sickness in pregnant women. The results were devastating: 12,000 children were born with...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

PTAB post-SAS: what we know and what questions remain https://t.co/KMJKfQPxFE Eight weeks on from the US Supreme Co… https://t.co/lK38MD7Kj4

Jun 21 2018 12:40 ·  reply ·  retweet ·  favourite
ManagingIP profile

EU legal affairs committee adopts controversial copyright directive - our analysis https://t.co/ykTKfUocqj Provisio… https://t.co/699BhUHVzY

Jun 20 2018 12:42 ·  reply ·  retweet ·  favourite
ManagingIP profile

The controversial Article 13 'value gap proposal' has been adopted into the draft Directive on Copyright in the Dig… https://t.co/mbi6s6UFFP

Jun 20 2018 09:07 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null

null null null

null null null

May 2018

Technology alters the anti-counterfeiting landscape

Ellie Mertens reveals evolving technologies are changing the counterfeiting game on both sides, as a tool for both prevention and evasion



Most read articles

Supplements